This content is restricted.
Brief
On "20/06/2025", the "Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor)" issued an update regarding "The risks and benefits of the use of artificial intelligence in epidemiology were discussed at the PMEF". The discussion highlighted the need for responsible AI application, especially in biology, to prevent potential risks and ensure safe and effective use. Participants emphasized the importance of regulation, education, and human oversight to mitigate the risks associated with AI in epidemiology.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested